Global Male Infertility Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
MarketResearch.Biz delivers in-depth insights on male infertility treatment and the global market in its upcoming report titled “Global Male Infertility Treatment Market Trends, Applications, Analysis, Growth, and Forecast to 2027”. The global male infertility treatment market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the global male infertility treatment market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global male infertility treatment market report has been segmented on the basis of test, application, and region.
Male infertility is a widespread disorder in which a man is unable to impregnate a fertile female. If in 12 months of unprotected intercourse the couple is unable to conceive, then infertility can be viewed as a cause. One of the major causes for male infertility is stress. High levels of oxidative stress can damage normal spermatozoa by inducing lipid peroxidation and DNA damage, and are associated with poor sperm production and subfertility. Moreover, prevalence of chronic diseases such as Azoospermia, testosterone deficiency, prostate cancer and other diseases, abnormal sperm function or blockages, illnesses, injuries, torpid lifestyle, consumption of alcohol or drugs, smoking, and obesity can also play a role in causing male infertility. These are major factors driving growth of the global male infertility market.
Male infertility factor is a primary cause for low birth rates in many countries across the globe. Males diagnosed with infertility tend to undergo high stress levels, embarrassment among other emotional changes, which further intensify the problem. Emotional shock and discontinuation of treatment is the key limitation which directly affects growth of the global male infertility market. In addition, high-cost of treatment is also another factor limiting market growth. However, opportunities expected to drive market growth in future include continuous R&D initiatives to develop more efficient cures, and introduction of low-cost treatments, rising medical tourism trend, rising disposable income, and increasing awareness among the male population regarding the potential benefits of treatments.
Region-wise, North America is dominating the global male infertility treatment market due to high literacy rate coupled with increasing number of healthcare centers. Europe is the second largest market for global male infertility treatment market, with growth mainly attributed to rising stress levels, obesity, and torpid lifestyle. The market in Asia Pacific is expected to witness highest CAGR during the analysis period owing to most of the above-mentioned factors along with increasing per capita income and spending capacity among consumers in the region.
Global Male Infertility Market Segmentation:
Global male infertility treatment market segmentation by test:
- DNA Fragmentation Technique
- Oxidative Stress Analysis
- Microscopic Examination
- Sperm Agglutination
- Computer Assisted Semen Analysis
- Sperm Penetration Assay
Global male infertility treatment market segmentation by technique:
- Assisted Reproductive Technology
Global male infertility treatment market segmentation by region:
- North America
- Asia Pacific
- Middle East & Africa
- Latin America
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- ASKA Pharmaceutical
- Halotech DNA
- Merck Serono
- Zydus Cadila Healthcare
- Apricus Biosciences
- Aytu BioScience
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!